Despite Controversy, Human Studies of CRISPR Move Forward in the U.S.

[Bok]

The technology that produced a global scandal in China last year has entered into clinical trials to treat sickle cell anemia and an eye disease

-- Read more on ScientificAmerican.comhttp://feeds.feedburner.com/~ff/ScientificAmerican-News?i=rzmX9rQyE4o:2QH43CdYE0Q:V_sGLiPBpWU (http://rss.sciam.com/~ff/ScientificAmerican-News?a=rzmX9rQyE4o:2QH43CdYE0Q:V_sGLiPBpWU) http://feeds.feedburner.com/~ff/ScientificAmerican-News?i=rzmX9rQyE4o:2QH43CdYE0Q:gIN9vFwOqvQ (http://rss.sciam.com/~ff/ScientificAmerican-News?a=rzmX9rQyE4o:2QH43CdYE0Q:gIN9vFwOqvQ) http://feeds.feedburner.com/~ff/ScientificAmerican-News?d=cGdyc7Q-1BI (http://rss.sciam.com/~ff/ScientificAmerican-News?a=rzmX9rQyE4o:2QH43CdYE0Q:cGdyc7Q-1BI) http://feeds.feedburner.com/~ff/ScientificAmerican-News?d=QXVau8BzmBE (http://rss.sciam.com/~ff/ScientificAmerican-News?a=rzmX9rQyE4o:2QH43CdYE0Q:QXVau8BzmBE) http://feeds.feedburner.com/~ff/ScientificAmerican-News?i=rzmX9rQyE4o:2QH43CdYE0Q:F7zBnMyn0Lo (http://rss.sciam.com/~ff/ScientificAmerican-News?a=rzmX9rQyE4o:2QH43CdYE0Q:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/ScientificAmerican-News?d=l6gmwiTKsz0 (http://rss.sciam.com/~ff/ScientificAmerican-News?a=rzmX9rQyE4o:2QH43CdYE0Q:l6gmwiTKsz0) http://feeds.feedburner.com/~ff/ScientificAmerican-News?d=I9og5sOYxJI (http://rss.sciam.com/~ff/ScientificAmerican-News?a=rzmX9rQyE4o:2QH43CdYE0Q:I9og5sOYxJI) http://feeds.feedburner.com/~ff/ScientificAmerican-News?d=qj6IDK7rITs (http://rss.sciam.com/~ff/ScientificAmerican-News?a=rzmX9rQyE4o:2QH43CdYE0Q:qj6IDK7rITs) http://feeds.feedburner.com/~ff/ScientificAmerican-News?d=yIl2AUoC8zA (http://rss.sciam.com/~ff/ScientificAmerican-News?a=rzmX9rQyE4o:2QH43CdYE0Q:yIl2AUoC8zA)
http://feeds.feedburner.com/~r/ScientificAmerican-News/~4/rzmX9rQyE4o

More... (http://rss.sciam.com/~r/ScientificAmerican-News/~3/rzmX9rQyE4o/)